Updated
Updated · Moneycontrol · Jun 4
Doctor Flags 3 Common Symptoms as Signs of Insulin Resistance in Women
Updated
Updated · Moneycontrol · Jun 4

Doctor Flags 3 Common Symptoms as Signs of Insulin Resistance in Women

1 articles · Updated · Moneycontrol · Jun 4

Summary

  • Persistent fatigue, sugar cravings and irregular periods may point to insulin resistance rather than stress, Dr Monica Kumbhat said, urging women not to ignore symptoms that last for months.
  • Excess insulin can drive constant hunger, daytime energy crashes and disrupted ovulation, creating a cycle in which sugary foods bring only brief relief before another slump follows.
  • Kumbhat said routine glucose checks can miss early metabolic dysfunction even when fasting sugar looks normal, making broader assessment important when symptoms overlap.
  • Tests increasingly used to uncover hidden insulin resistance include fasting insulin, HbA1c, lipid profiles, reproductive hormone panels and oral glucose tolerance monitoring.
  • Left unrecognized, the condition can raise risks of infertility, type 2 diabetes and cardiovascular disease, and is increasingly tied to a wider metabolic view of PCOS.

Insights

Fatigue and cravings can signal a hormonal 'vicious cycle'. How can you break free before it is too late?
PCOS has a new name. Why does this matter for millions of women whose symptoms have long been dismissed?
Can your smartwatch detect a serious metabolic condition before your doctor does?

Insulin Resistance in Women: The Shift from PCOS to PMOS, Early Warning Signs, and the New Era of Diagnosis and Treatment

Overview

This report highlights the recent evolution in understanding Polycystic Ovary Syndrome (PCOS), now proposed to be renamed as Polyendocrine Metabolic Ovarian Syndrome (PMOS). The change reflects a collective effort to better capture the condition’s true complexity and systemic nature, moving beyond the narrow focus on ovarian cysts. Guided by principles like patient benefit and scientific accuracy, this shift aims to improve care and drive global advancements in research and clinical practice. By adopting the new name and approach, healthcare providers can offer more comprehensive and effective management for those affected by this multifaceted disorder.

...